Robert Coffin - May 16, 2022 Form 4 Insider Report for Replimune Group, Inc. (REPL)

Role: President & Chief R&D Officer, Director
Signature: /s/ Jean Franchi, attorney-in-fact
Stock symbol: REPL
Transactions as of: May 16, 2022
Transactions value $: -$83,703
Form type: 4
Date filed: 5/18/2022, 07:01 PM
Previous filing: Apr 5, 2022
Next filing: Apr 4, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	REPL	Common Stock	Sale	-$83.7K	-5.74K	-0.32%	$14.59	1.8M	May 16, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person.

Content

Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person.